Novo Nordisk As Stock Alpha and Beta Analysis
| NVO Stock | USD 85.34 1.31 1.56% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Novo Nordisk AS. It also helps investors analyze the systematic and unsystematic risks associated with investing in Novo Nordisk over a specified time horizon. Remember, high Novo Nordisk's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Novo Nordisk's market risk premium analysis include:
Beta 0.0138 | Alpha (0.45) | Risk 3.24 | Sharpe Ratio (0.12) | Expected Return (0.40) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Novo |
Novo Nordisk Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Novo Nordisk market risk premium is the additional return an investor will receive from holding Novo Nordisk long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Novo Nordisk. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Novo Nordisk's performance over market.| α | -0.45 | β | 0.01 |
Novo Nordisk expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Novo Nordisk's Buy-and-hold return. Our buy-and-hold chart shows how Novo Nordisk performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Novo Nordisk Market Price Analysis
Market price analysis indicators help investors to evaluate how Novo Nordisk stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Novo Nordisk shares will generate the highest return on investment. By understating and applying Novo Nordisk stock market price indicators, traders can identify Novo Nordisk position entry and exit signals to maximize returns.
Novo Nordisk Return and Market Media
The median price of Novo Nordisk for the period between Fri, Nov 1, 2024 and Thu, Jan 30, 2025 is 105.32 with a coefficient of variation of 11.91. The daily time series for the period is distributed with a sample standard deviation of 11.83, arithmetic mean of 99.31, and mean deviation of 10.95. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Eli Lillys Zepbound Drug Likely To Dominate Global Obesity Market Report | 12/31/2024 |
2 | Ozempic 3.0 This drug causes the greatest weight loss by far | 01/06/2025 |
3 | Novo Nordisk Expands AI Collaboration for Drug Development | 01/10/2025 |
4 | Jim Cramer on Novo Nordisk AS Thats Denmarks Jugular | 01/14/2025 |
5 | Deal of the century How much would Trump have to pay for Greenland | 01/15/2025 |
6 | Denmark summons business leaders over Trumps Greenland remarks | 01/16/2025 |
7 | Meet Super Ozempic Higher Dose Semaglutide Leads to Even Greater Weight Loss In Major Trial | 01/17/2025 |
About Novo Nordisk Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Novo or other stocks. Alpha measures the amount that position in Novo Nordisk AS has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 | 2025 (projected) | Dividend Yield | 0.0119 | 0.0102 | 0.009136 | 0.0154 | Price To Sales Ratio | 12.01 | 13.47 | 12.13 | 12.73 |
Novo Nordisk Upcoming Company Events
As portrayed in its financial statements, the presentation of Novo Nordisk's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Novo Nordisk's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Novo Nordisk's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Novo Nordisk. Please utilize our Beneish M Score to check the likelihood of Novo Nordisk's management manipulating its earnings.
| 31st of January 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 31st of January 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Novo Nordisk
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Novo Nordisk Backtesting, Novo Nordisk Valuation, Novo Nordisk Correlation, Novo Nordisk Hype Analysis, Novo Nordisk Volatility, Novo Nordisk History and analyze Novo Nordisk Performance. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Novo Nordisk technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.